The agenda for the 22 October meeting of the Transparency Commission is now available.  The Commission will consider the listing of the following medicines:

• Izinova (sodium sulphate anhydrous) - new formulation
• Kalydeco (ivacaftor) - new indication
• Byetta (exenatide) - new indication

For more details, go to: http://www.has-sante.fr/portail/upload/docs/application/pdf/2014-10/odj_ct_22102014_internet.pdf [French]